Failure of rituximab to treat a lupus flare-up with nephritis

Clinical Nephrology

Volumn 64, Issue 1, 2005, Pages 73-77

  Lambotte, Olivier ^a   Durbach A ^a   Kotb, R ^a   Ferlicot, S ^a   Delfraissy, J F ^a   Goujard, C ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Glomerulonephritis; Rituximab; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG USE; FEMALE; HUMAN; LEUKOCYTURIA; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRITIS; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TREATMENT FAILURE;

EID: 22144462880     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64073     Document Type: Article

References (15)

1. Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD 2003 Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48: 2146-2154
2. Cortes-Hernandez J, Ordi-Ros J, Labrador M, Bujan S, Balada E, Segarra A, Vilardell-Tarres M 2004 Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 116: 165-173
3. Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D 1989 Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol 16: 614-617
4. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al 2004 Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350: 2572-2581
5. Fra GP, Avanzi GC, Bartoli E 2003 Remission of refractory lupus nephritis with a protocol including rituximab. Lupus 12: 783-787
6. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB 2000 Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6: 114
7. Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA 2002 An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46: 2673-2677
8. Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B 2002 Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol 116: 465-467
9. Reff M, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R et al 1994 Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83: 435-445
10. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR 2001 Systemic lupus erythematosus. Lancet 357: 1027-1032
11. Saito K, Nawata M, Nakayamada S, Tokunaga M, Tsukada J, Tanaka Y 2003 Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement. Lupus 12: 798-800
12. Silverman GJ, Weisman S 2003 Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 48: 1484-1492
13. Specks U, Fervenza FC, McDonald TJ, Hogan MC 2001 Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44: 2836-2840
14. Stasi R, Pagano A, Stipa E, Amadori S 2001 Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98: 952-957
15. Weide R, Heymanns J, Pandorf A, Koppler H 2003 Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 12: 779-782